The published findings suggest that there may be some additional benefit in decreasing hip fracture risk for women over age 60. How big is this benefit and is it statistically significant?
The most scientifically reliable findings from the CaD Trial are the overall non-significant effect of CaD supplements on risk of hip fracture. Among women 60 years of age and older, those assigned to active CaD had a 21% decreased risk of hip fracture compared to women 60 and over who were taking placebo (17 compared to 23 cases per 10,000 women each year, on average). This difference was statistically significant. Further research is needed to understand the findings about differences by age.
